Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.3 USD | +0.05% | +2.14% | -4.77% |
01:06pm | J&J: encouraging results in prostate cancer | CF |
12:26pm | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 359B | |
+26.08% | 662B | |
+20.61% | 546B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.12% | 198B | |
-10.47% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Street Color: Johnson & Johnson CFO Expects Not-For-Profit COVID-19 Vaccine Price at $8/Dose